Enliven Therapeutics (ELVN) Market Capitalization (2020 - 2026)
Enliven Therapeutics' Market Capitalization was $3.72 billion in Q2 2026, up 212.9% from $1.19 billion a year earlier and up 55.7% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Market Capitalization (2020 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Enliven Therapeutics came in at $915.38 million, down 16.9% from FY2024.
- Market Capitalization shows a five-year compound annual growth rate of 24.4% (FY2020 to FY2025).
- In earlier years, Market Capitalization was $1.1 billion in FY2024 (+92.7%), $571.48 million in FY2023 (+431.5%), $107.51 million in FY2022 (+120.6%) and $48.74 million in FY2021 (-84.1%).
- The Q2 2026 figure marks the highest quarterly Market Capitalization in data going back to Q1 2020.
- Compared with a year earlier, Market Capitalization was higher in seven of the last eight quarters, with growth averaging 72.0%.
- The best year-over-year quarter for Market Capitalization over five years was Q3 2023 (growth of 839.1%); the worst was Q4 2021 (a decline of 84.1%).
- Per Business Quant data, ELVN's Market Capitalization in the three quarters before Q2 2026 was $2.39 billion (Q1 2026), $915.38 million (Q4 2025) and $1.21 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Enliven Therapeutics | 3.36 Bn | 3.36 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.72 Bn |
| Mar 31, 2026 | 2.39 Bn |
| Dec 31, 2025 | 915.38 Mn |
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.19 Bn |
| Mar 31, 2025 | 965.08 Mn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.10 Bn |
| Mar 31, 2024 | 822.91 Mn |
| Dec 31, 2023 | 571.48 Mn |
| Sep 30, 2023 | 562.86 Mn |
| Jun 30, 2023 | 839.89 Mn |
| Mar 31, 2023 | 405.47 Mn |
| Dec 31, 2022 | 107.51 Mn |
| Sep 30, 2022 | 59.93 Mn |
| Jun 30, 2022 | 32.07 Mn |
| Mar 31, 2022 | 49.42 Mn |
| Dec 31, 2021 | 48.74 Mn |
| Sep 30, 2021 | 107.20 Mn |
API Access
Enliven Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();